Evaluation of Chlamydia psittaci subfraction and subunit preparations for their protective capacities

Veterinary Microbiology

Volumn 48, Issue 3-4, 1996, Pages 269-282

  Sandbulte, Jim ^a   TerWee, Julie ^b   Wigington, Ken ^b   Sabara, Marta ^b  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^b NONE

Author keywords

Chlamydia psittaci; Outer membrane protein; Vaccines

Indexed keywords

LIPOPOLYSACCHARIDE; OUTER MEMBRANE PROTEIN; VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAT; CHLAMYDIACEAE; CHLAMYDIASIS; CONTROLLED STUDY; MOUSE; NONHUMAN; TOXICITY TESTING; VACCINATION;

EID: 0029987067     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-1135(95)00166-2     Document Type: Article

References (25)

1. Bavoil, P., Ohlin, A. and Schachter, J., 1984. Role of disulfide bonding in outer membrane structure and permeability in Chlamydia trachomatis. Infect. Immun., 44: 479-485.
2. Caldwell, H.D. and Perry, L.J., 1982. Neutralization of Chlamydia trachomatis infectivity with antibodies to the major outer membrane protein. Infect. Immun., 38: 745-754.
3. Caldwell, H.D., Kromhout, J. and Schachter, J., 1981. Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect. Immun., 31: 1161-1176.
4. Cello, R.M., 1967. Ocular infections of animals with PLT (Bedsonia) group agents. Am. J. Ophthalmol., 63: 1270-1273.
5. Clements, C. and Dhir, S.P., 1979. Long-term follow-up study of a trachoma vaccine trial in villages of Northern India. Am. J. Ophthalmol., 87: 350-355.
6. Grayston, J.T. and Wang, S., 1975. New knowledge of Chlamydiae and the diseases they cause. J. Infect. Dis., 132: 87-90.
7. Ishizaki, M., Allen, J.E., Beatty, P.R. and Stephens, R.S., 1992. Immune specificity of murine T-cell lines to the major outer membrane protein of Chlamydia trachomatis. Infect. Immun., 60: 3714-3718.
8. Laemmli, U.K., 1970. Cleavage of structural protein during the assembly of the head of bacteriophage T4. Nature (London), 227: 680-685.
9. Morrisey, J.M., 1981. A silver stain procedure. Anal. Biochem., 117: 307-310.
10. Morrison, R.P., Lyng, K. and Caldwell, H.D., 1989. Chlamydial disease pathogenesis. Ocular hypersensitivity elicited by a genus-specific 57-kDa protein. J. Exp. Med., 169: 663-675.
11. Pedersen, N.C., 1988. Chlamydiosis, In: P.W. Pratt and S.E. Aiello (Eds.), Feline Infectious Diseases, American Veterinary Publications Inc., Goleta, USA, pp. 231-233.
12. Rank, R.G., Soderberg, L.S.F., Sander, M.M. and Batteiger, B.E., 1989. Role of cell-mediated immunity in the resolution of secondary chlamydial genital infection in guinea pigs infected with the agent of guinea pig inclusion conjunctivitis. Infect. Immun., 57: 706-710.
13. Rank, R.G., Ramsey, K.H., Pack, E.A. and Williams, D.M., 1992. Effect of gamma interferon on resolution of murine Chlamydial genital infection. Infect. Immun., 60: 4427-4429.
14. Rodolakis, A., Bernard, F. and Lantier, F., 1989. Mouse models for evaluation of virulence of Chlamydia psittaci isolated from ruminants. Res. Vet. Sci., 46: 34-39.
15. Schagger, H. and von Jagow, G., 1987. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of protein in the range from 1 to 100 kDa. Anal. Biochem., 166: 368-379.
16. Shewen, P.E., Povey, R.C. and Wilson, M.R., 1980. A comparison of the efficacy of a live and four inactivated vaccine preparations for the protection of cats against experimental challenge with Chlamydia psittaci. Can. J. Comp. Med., 44: 244-251.
17. Stephens, R.S., 1992. Challenge of Chlamydia research. Infect. Agents Dis., 1: 279-293.
18. Su, H. and Caldwell, H.D., 1993. Immunogenicity of a synthetic oligopeptide corresponding to antigenically common T-helper and B-cell neutralizing epitopes of the major outer membrane protein of Chlamydia trachomatis. Vaccine, 11: 1159-1166.
19. Su, H., Morrison, R.P., Watkins, N.G. and Caldwell, H.D., 1990. Identification and characterization of T helper cell epitopes of the major outer membrane protein of Chlamydia trachomatis. J. Exp. Med., 172: 203-212.
20. Taylor-Robinson, D. and Thomas, B.J., 1980. The role of Chlamydia trachomatis in genital tract and associated diseases. J. Clin. Pathol., 33: 205-233.
21. Tan, T.W., Herring, A.J., Anderson, I.E. and Jones, G.E., 1990. Protection of sheep against Chlamydia psittaci infection with a subcellular vaccine containing the major outer membrane protein. Infect. Immun., 58: 3101-3108.
22. Taylor, H.R. and Prendergast, R.A., 1987. Attempted oral immunization with Chlamydial lipopolysaccharide subunit vaccine. Invest. Ophthalmol. Vis. Sci., 28: 1722-1726.
23. Taylor, H.R., Whittum-Hudson, J., Schachter, J., Caldwell, H.D. and R.A. Prendergast., 1988. Oral immunization with Chlamydia major outer membrane protein (MOMP). Invest. Ophthalmol. Vis. Sci., 29: 1847-1853.
24. Wills, J.M., Gruftydo-Jones, T.J., Richmond, S.J., Gaskell, R.M. and Bourne, F.J., 1987. Effect of vaccination on feline Chlamydia psittaci infection. Infect. Immun., 55: 2653-2657.
25. Zang, Y.X., Stewart, S., Joseph, T., Taylor, H.R. and Caldwell, H.D., 1987. Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis. J. Immunol., 138: 575-581.